MYOF
Basic information
Region (hg38): 10:93306429-93482334
Previous symbols: [ "FER1L3" ]
Links
Phenotypes
GenCC
Source:
- angioedema, hereditary, 7 (Limited), mode of inheritance: Unknown
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Angioedema, hereditary, 7 | AD | Allergy/Immunology/Infectious | The condition can involved episodes of angioedema, and medical management may be beneficial | Allergy/Immunology/Infectious | 32542751 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MYOF gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 10 | 14 | ||||
missense | 170 | 11 | 187 | |||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 2 | 1 | 4 | ||
non coding | 2 | |||||
Total | 0 | 0 | 171 | 23 | 10 |
Variants in MYOF
This is a list of pathogenic ClinVar variants found in the MYOF region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
10-93310040-C-T | not specified | Uncertain significance (Nov 14, 2023) | ||
10-93310047-G-T | not specified | Uncertain significance (Oct 14, 2023) | ||
10-93310108-A-G | Uncertain significance (Feb 01, 2024) | |||
10-93310526-CCT-C | MYOF-related disorder | Likely benign (Jul 03, 2024) | ||
10-93310543-T-C | Uncertain significance (Jul 01, 2023) | |||
10-93310566-T-C | Uncertain significance (Apr 01, 2021) | |||
10-93310568-C-T | not specified | Uncertain significance (Aug 01, 2024) | ||
10-93310574-G-A | not specified | Uncertain significance (Oct 10, 2023) | ||
10-93310574-G-T | MYOF-related disorder | Likely benign (Aug 06, 2019) | ||
10-93310598-C-T | not specified | Uncertain significance (Sep 13, 2023) | ||
10-93310601-C-T | not specified | Uncertain significance (Jan 03, 2024) | ||
10-93310611-G-A | MYOF-related disorder | Likely benign (Sep 18, 2019) | ||
10-93310612-T-C | not specified | Uncertain significance (Dec 19, 2023) | ||
10-93313030-C-T | not specified | Uncertain significance (Dec 03, 2024) | ||
10-93313031-G-A | not specified | Uncertain significance (Sep 24, 2024) | ||
10-93313049-C-T | not specified | Uncertain significance (May 09, 2022) | ||
10-93313094-A-T | not specified | Uncertain significance (Aug 19, 2024) | ||
10-93313114-G-T | not specified | Uncertain significance (Feb 27, 2023) | ||
10-93313124-C-T | not specified | Uncertain significance (Feb 13, 2024) | ||
10-93313135-G-A | not specified | Uncertain significance (May 04, 2022) | ||
10-93313142-T-A | Uncertain significance (Jul 01, 2023) | |||
10-93313149-T-C | Benign (Mar 23, 2020) | |||
10-93313171-G-A | not specified | Uncertain significance (Feb 10, 2022) | ||
10-93313190-G-A | not specified • MYOF-related disorder | Uncertain significance (Dec 14, 2022) | ||
10-93316745-G-T | Likely benign (Mar 01, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MYOF | protein_coding | protein_coding | ENST00000359263 | 54 | 175889 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.48e-54 | 0.00217 | 124357 | 2 | 690 | 125049 | 0.00277 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.112 | 1156 | 1.17e+3 | 0.991 | 0.0000666 | 13537 |
Missense in Polyphen | 439 | 456.57 | 0.96152 | 5398 | ||
Synonymous | 0.279 | 430 | 437 | 0.983 | 0.0000265 | 3880 |
Loss of Function | 2.49 | 101 | 132 | 0.766 | 0.00000743 | 1448 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00676 | 0.00674 |
Ashkenazi Jewish | 0.00457 | 0.00458 |
East Asian | 0.00274 | 0.00270 |
Finnish | 0.00112 | 0.00111 |
European (Non-Finnish) | 0.00224 | 0.00223 |
Middle Eastern | 0.00274 | 0.00270 |
South Asian | 0.00485 | 0.00478 |
Other | 0.00198 | 0.00198 |
dbNSFP
Source:
- Function
- FUNCTION: Calcium/phospholipid-binding protein that plays a role in the plasmalemma repair mechanism of endothelial cells that permits rapid resealing of membranes disrupted by mechanical stress. Involved in endocytic recycling. Implicated in VEGF signal transduction by regulating the levels of the receptor KDR (By similarity). {ECO:0000250}.;
- Pathway
- Aryl Hydrocarbon Receptor Pathway;Nuclear Receptors Meta-Pathway;Hepatitis C and Hepatocellular Carcinoma;Signaling events mediated by VEGFR1 and VEGFR2
(Consensus)
Recessive Scores
- pRec
- 0.134
Intolerance Scores
- loftool
- 0.0903
- rvis_EVS
- -0.44
- rvis_percentile_EVS
- 24.68
Haploinsufficiency Scores
- pHI
- 0.195
- hipred
- N
- hipred_score
- 0.492
- ghis
- 0.539
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.517
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Myof
- Phenotype
- muscle phenotype; growth/size/body region phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan);
Gene ontology
- Biological process
- plasma membrane repair;glycerol metabolic process;muscle contraction;myoblast fusion;blood circulation;regulation of vascular endothelial growth factor receptor signaling pathway;T-tubule organization;cellular response to heat;muscle fiber development
- Cellular component
- nuclear envelope;plasma membrane;caveola;integral component of membrane;cytoplasmic vesicle membrane;cytoplasmic vesicle;nuclear membrane;intracellular membrane-bounded organelle;extracellular exosome
- Molecular function
- protein binding;phospholipid binding